CDC and FDA are investigating a multistate botulism-like illness outbreak due to counterfeit Botox injections.

At least 19 women across nine states have been affected, with several hospitalizations.

Public health authorities recommend ensuring Botox providers are properly trained and licensed.

The FDA has released information to help identify counterfeit Botox packaging.

The ASDSA is advocating for stronger regulation in the administration of medical care.

Consumers are advised to verify Botox authenticity and no issues reported with approved Botox.